Aug 29, 2013, 05.15 PM IST | Source: CNBC-TV18

Book some profits in Ranbaxy around Rs 415-420: Paul

According to Abhijit Paul, Founder of Alphative Advisors LLP, one may book some profits in Ranbaxy Laboratories around Rs 415-420.

Abhijit Paul, Founder of Alphative Advisors LLP told CNBC-TV18, "Pharmaceutical sector has played quite a critical role for a couple of years now. Most of the names like Dr Reddys Laboratories , Sun Pharmaceutical Industries or Lupin have been in quite a strong uptrend for quite some time. The recent six weeks sell-off that we have seen in the market, it was a rare event that we have seen the healthcare names and the fast moving consumer goods (FMCG) ones come off quite sharply.”

“We have a decent bounce back in our hands now and keeping in mind that the underline long-term trends are fairly strong, there can be a short-term long bet in names like Dr Reddy's, Lupin as well but Ranbaxy Laboratories moved quite sharply and close to that Rs 415-420 range, it has some amount of serious supply. So if one has made use of this move in the stock, this is the kind of range where one should take some profit of the table.”

Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Arvind Kejriwal

1695.71 -35.05 -2.03%

54071

Bought today

83300

Sold today

0.62%

User holding

video of the day

Add cyclicals, banks on positive poll outcome: UBS

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.